Suppr超能文献

造血系统恶性肿瘤家族史与非霍奇金淋巴瘤(NHL)风险:来自国际淋巴瘤流行病学联盟(InterLymph)的10211例病例和11905例对照的汇总分析

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

作者信息

Wang Sophia S, Slager Susan L, Brennan Paul, Holly Elizabeth A, De Sanjose Silvia, Bernstein Leslie, Boffetta Paolo, Cerhan James R, Maynadie Marc, Spinelli John J, Chiu Brian C H, Cocco Pier Luigi, Mensah Fiona, Zhang Yawei, Nieters Alexandra, Dal Maso Luigino, Bracci Paige M, Costantini Adele Seniori, Vineis Paolo, Severson Richard K, Roman Eve, Cozen Wendy, Weisenburger Dennis, Davis Scott, Franceschi Silvia, La Vecchia Carlo, Foretova Lenka, Becker Nikolaus, Staines Anthony, Vornanen Martine, Zheng Tongzhang, Hartge Patricia

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Bethesda, MD 20892, USA.

出版信息

Blood. 2007 Apr 15;109(8):3479-88. doi: 10.1182/blood-2006-06-031948. Epub 2006 Dec 21.

Abstract

A role for genetic susceptibility in non-Hodgkin lymphoma (NHL) is supported by the accumulating evidence of common genetic variations altering NHL risk. However, the pattern of NHL heritability remains poorly understood. We conducted a pooled analysis of 10 211 NHL cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph) to evaluate NHL risk among those with hematopoietic malignancies in first-degree relatives. Odds ratios (ORs) and 95% confidence intervals (CIs) of NHL and its subtypes were estimated from unconditional logistic regression models with adjustment for confounders. NHL risk was elevated for individuals who reported first-degree relatives with NHL (OR = 1.5; 95% CI = 1.2-1.9), Hodgkin lymphoma (OR = 1.6; 95% CI = 1.1-2.3), and leukemia (OR = 1.4; 95% CI = 1.2-2.7). Risk was highest among individuals who reported a brother with NHL (OR = 2.8; 95% CI = 1.6-4.8) and was consistent for all NHL subtypes evaluated. If a first-degree relative had Hodgkin lymphoma, NHL risk was highest if the relative was a parent (OR = 1.7; 95% CI = 1.0-2.9). If a first-degree relative had leukemia, NHL risk was highest among women who reported a sister with leukemia (OR = 3.0; 95% CI = 1.6-5.6). The pattern of NHL heritability appeared to be uniform across NHL subtypes, but risk patterns differed by specific hematopoietic malignancies and the sex of the relative, revealing critical clues to disease etiology.

摘要

常见基因变异改变非霍奇金淋巴瘤(NHL)风险的证据不断积累,这支持了遗传易感性在NHL发病中所起的作用。然而,NHL的遗传模式仍知之甚少。我们对国际淋巴瘤流行病学联盟(InterLymph)的10211例NHL病例和11905例对照进行了汇总分析,以评估一级亲属患有造血系统恶性肿瘤者患NHL的风险。通过无条件逻辑回归模型估计NHL及其亚型的比值比(OR)和95%置信区间(CI),并对混杂因素进行校正。报告有患NHL的一级亲属的个体,其患NHL的风险升高(OR = 1.5;95%CI = 1.2 - 1.9),患霍奇金淋巴瘤的风险升高(OR = 1.6;95%CI = 1.1 - 2.3),患白血病的风险升高(OR = 1.4;95%CI = 1.2 - 2.7)。报告有患NHL的兄弟的个体风险最高(OR = 2.8;95%CI = 1.6 - 4.8),且在所评估的所有NHL亚型中风险一致。如果一级亲属患有霍奇金淋巴瘤,若该亲属为父母,则患NHL的风险最高(OR = 1.7;95%CI = 1.0 - 2.9)。如果一级亲属患有白血病,报告有患白血病姐妹的女性患NHL的风险最高(OR = 3.0;95%CI = 1.6 - 5.6)。NHL的遗传模式在各NHL亚型中似乎是一致的,但风险模式因特定的造血系统恶性肿瘤以及亲属的性别而异,这揭示了疾病病因的关键线索。

相似文献

2
Family history of hematopoietic malignancy and risk of lymphoma.
J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293.
3
Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphoma.
Cancer Causes Control. 2007 May;18(4):351-9. doi: 10.1007/s10552-006-0088-5. Epub 2007 Jan 6.
4
Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
Environ Health Perspect. 2016 Apr;124(4):396-405. doi: 10.1289/ehp.1409294. Epub 2015 Sep 4.
5
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44. doi: 10.1093/jncimonographs/lgu013.
6
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14. doi: 10.1093/jncimonographs/lgu005.
8
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
Int J Cancer. 2008 May 1;122(9):2062-70. doi: 10.1002/ijc.23344.

引用本文的文献

1
Common origin and somatic mutation patterns of composite lymphomas and leukemias.
Leukemia. 2025 May 22. doi: 10.1038/s41375-025-02549-y.
2
Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies.
J Natl Cancer Cent. 2022 Aug 17;2(4):226-234. doi: 10.1016/j.jncc.2022.08.003. eCollection 2022 Dec.
3
Epidemiology and etiology of diffuse large B-cell lymphoma.
Semin Hematol. 2023 Nov;60(5):255-266. doi: 10.1053/j.seminhematol.2023.11.004. Epub 2023 Nov 27.
4
Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes.
Cancer Epidemiol Biomarkers Prev. 2023 Feb 6;32(2):233-241. doi: 10.1158/1055-9965.EPI-22-0247.
5
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
Leukemia. 2022 Dec;36(12):2835-2844. doi: 10.1038/s41375-022-01711-0. Epub 2022 Oct 22.
6
Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders.
Sci Rep. 2022 Apr 12;12(1):6138. doi: 10.1038/s41598-022-09602-1.
7
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.
J Transl Genet Genom. 2021;5:200-217. doi: 10.20517/jtgg.2021.08. Epub 2021 Jun 17.
8
Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer.
Cancers (Basel). 2021 Jun 16;13(12):3023. doi: 10.3390/cancers13123023.
10
Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1844-1855. doi: 10.1158/1055-9965.EPI-20-0228. Epub 2020 Jul 29.

本文引用的文献

1
Non-Hodgkin's lymphoma and family history of hematologic malignancy.
Am J Epidemiol. 2007 Jan 15;165(2):126-33. doi: 10.1093/aje/kwj361. Epub 2006 Oct 27.
2
Influence of familial cancer history on lymphoid neoplasms risk validated in the large European case-control study epilymph.
Eur J Cancer. 2006 Oct;42(15):2570-6. doi: 10.1016/j.ejca.2006.03.031. Epub 2006 Aug 22.
3
Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco Bay Area.
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1287-94. doi: 10.1158/1055-9965.EPI-06-0066.
4
Family history of hemolymphopoietic and other cancers and risk of non-Hodgkin's lymphoma.
Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):245-50. doi: 10.1158/1055-9965.EPI-05-0553.
5
Reliability of self-reported family history of cancer in a large case-control study of lymphoma.
J Natl Cancer Inst. 2006 Jan 4;98(1):61-8. doi: 10.1093/jnci/djj005.
7
Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2402-6. doi: 10.1158/1055-9965.EPI-05-0346.
8
Family history of hematopoietic malignancy and risk of lymphoma.
J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293.
9
Key concepts in genetic epidemiology.
Lancet. 2005;366(9489):941-51. doi: 10.1016/S0140-6736(05)67322-9.
10
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Blood. 2006 Jan 1;107(1):265-76. doi: 10.1182/blood-2005-06-2508. Epub 2005 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验